-
Treatment Patterns, Clinical Outcomes, Health Care Resource Use and Costs in Older Adults with Malignant Pleural Mesothelioma in the United States
Mar 10, 2025, 14:00 PM -
Payer Survey Uncovers Likely Increased Management Strategies Following Release of Initial 10 Drugs Selected for Price Negotiation
Mar 10, 2025, 14:00 PM -
Comparing Predicted vs. Real-World Spending in the United States for Single-Administration Cell and Gene Therapies
Mar 10, 2025, 14:00 PM -
Patient Voice in Rare Disease Health Technology Assessments: Recent Trends in the Use of Qualitative Research in Reimbursement Submissions to Canada's Drug Agency
Mar 10, 2025, 14:00 PM -
Advancing the Development of Real-World Data for Cancer Care in China: Challenges and Opportunities
Mar 10, 2025, 14:00 PM -
Avoidable Costs by the Inclusion Ff Finerenone in Terms of Hospitalization Due to Heart Failure (HF) and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia
Mar 10, 2025, 14:00 PM -
Humanistic Burden in Metastatic Triple-Negative Breast Cancer (mTNBC): A Systematic Literature Review (SLR)
Mar 10, 2025, 14:00 PM -
Disparities in Access to COPD Medications in Brazil - Impact of Geography and Socioeconomic Factors on Patient Travel Distances
Mar 10, 2025, 14:00 PM -
A Cost Per Responder Analysis of Ritlecitinib and Baricitinib: Assessing the Impact of Clinical Efficacy and Dosing Variability on Overall Treatment Costs of Severe Alopecia Areata (AA)
Mar 10, 2025, 14:00 PM -
Revolutionizing Multi-Level Network Meta-Regression: Advancing Analysis With the Package
Mar 10, 2025, 14:00 PM -
Incorporating Social Drivers of Health Information Into Health Economics and Outcomes Research: Neighborhood-Level Proxies Versus Individual Level Data
Mar 10, 2025, 14:00 PM -
Are Workforce Productivity Measures Useful for Formulary Management Decision-Making?
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in HER2-Positive Early Breast Cancer in China: A Post-Hoc Analysis of the FeDeriCa Trial
Mar 10, 2025, 14:00 PM -
Eosinophilic Esophagitis-Related Healthcare Resource Utilization and Associated Costs for Payers and Patients: A Retrospective Cohort Study of US Health Insurance Claims Data
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Exagamglogene Autotemcel (Exa-cel) on Health Inequalities in Patients with Sickle Cell Disease in the United Kingdom and Canada
Mar 10, 2025, 14:00 PM -
Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic HR+ HER2- Breast Cancer
Mar 10, 2025, 14:00 PM -
Analysis of Real-World Evidence Use Across FDA Submissions in 2022 and 2023
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Revumenib for the Treatment of Relapsed or Refractory Acute Leukemias With a KMT2A Translocation in the United States
Mar 10, 2025, 14:00 PM -
Pressures Behind the Rising Costs in Canadian Private Drug Plans: 2018-2023
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Momelotinib for the Treatment of Adult Patients With Myelofibrosis and Anemia in Canada
Mar 10, 2025, 14:00 PM
